Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab von Economopoulou, Panagiota, Kotoula, Vassiliki, Koliou, Georgia-Angeliki, Papadopoulou, Kyriaki, Christodoulou, Christos, Pentheroudakis, George, Lazaridis, Georgios, Arapantoni-Dadioti, Petroula, Koutras, Angelos, Bafaloukos, Dimitris, Papakostas, Pavlos, Patsea, Helen, Pavlakis, Kitty, Pectasides, Dimitrios, Kotsakis, Athanasios, Razis, Evangelia, Aravantinos, Gerasimos, Samantas, Epaminondas, Kalogeras, Konstantine T., Economopoulos, Theofanis, Psyrri, Amanta, Fountzilas, George

Volltext

Carboplatin Plus Paclitaxel in Unknown Primary Carcinoma: A Phase II Hellenic Cooperative Oncology Group Study von BRIASOULIS, E, KALOFONOS, H, BAFALOUKOS, D, SAMANTAS, E, FOUNTZILAS, G, XIROS, N, SKARLOS, D, CHRISTODOULOU, C, KOSMIDIS, P, PAVLIDIS, N

Volltext

Abstract P2-15-07: Real-world multicenter, prospective study of the effects of nab -paclitaxel on clinical outcomes and quality of life of patients with metastatic breast cancer in... von Koumarianou, Anna, Makrantonakis, Paris, Zagouri, Flora, Papadimitriou, Christos, Christopoulou, Athina, Samantas, Epaminontas, Christodoulou, Christos, Psyrri, Amanda, Bafaloukos, Dimitris, Aravantinos, Gerasimos, Papakotoulas, Pavlos, Baka, Sofia, Andreadis, Charalampos, Alexopoulos, Athanasios, Bombolaki, Iliada, Kampoli, Katerina, Liori, Sofia, Karvounis, Kiki, Ardavanis, Alexandros

Volltext

Evaluation of the effect of CXCL13 mRNA expression in early breast cancer outcome: A confirmatory study von Razis, Evangelia, Kotsantis, Ioannis, Manousou, Kyriaki, Wirtz, Ralph M, Zagouri, Flora, Lazaridis, George, Gogas, Helen, Veltrup, Elke, Koutras, Angelos, Pentheroudakis, George E., Christodoulou, Christos, Bafaloukos, Dimitris, Papakostas, Pavlos, Xanthakis, Ioannis, Kalogeras, Konstantine T., Dimopoulos, Meletios A., Fountzilas, George

Volltext

Vemurafenib treatment in patients with BRAF-mutated melanoma failing MEK inhibition with trametinib von Gogas, Helen, Schadendorf, Dirk, Dummer, Reinhard, Garbe, Claus, Lebbe, Celeste, Nathan, Paul D., Larkin, James M. G., Haydon, Andrew Mark, Bafaloukos, Dimitris, Robert, Caroline

Volltext

Tumor infiltrating lymphocytes and hydrophobic amino acid changes in HER2-positive metastatic breast cancer von Kotoula, Vassiliki, Giannoulatou, Eleni, Alexopoulou, Zoi, Karavasilis, Vasilios, Kotsakis, Athanasios, Dionysopoulos, Dimitrios, Christodoulou, Christos, Tsolaki, Eleftheria, Bobos, Mattheos, Charalambous, Elpida, Pentheroudakis, George E., Makatsoris, Thomas, Chrisafi, Sofia, Pectasides, Dimitrios G., Psyrri, Amanda, Papakostas, Pavlos, Razis, Evangelia, Bafaloukos, Dimitris, Georgoulias, Vasileios, Fountzilas, George

Volltext

Randomized phase III trial of FOLFOX versus XELOX as adjuvant chemotherapy in patients with early-stage colorectal adenocarcinoma von Pectasides, Dimitrios G., Papaxoinis, George, Xanthakis, Ioannis, Kouvatseas, George, Kotoula, Vassiliki, Xiros, Nikolaos, Samantas, Epaminondas, Papakostas, Pavlos, Klouvas, George, Varthalitis, Ioannis I., Pentheroudakis, George E., Fountzilas, George, Bafaloukos, Dimitris

Volltext

Multigene massively parallel sequencing (MPS) genomic patterns in bilateral breast cancers (BBC) to reveal patient-private disease evolution and heterogeneity von Fountzilas, Elena, Kotoula, Vassiliki, Zagouri, Flora, Alexopoulou, Zoi, Bobos, Mattheos, Chrisafi, Sofia, Zografos, George, Pentheroudakis, George E., Bafaloukos, Dimitris, Samantas, Epaminontas, Christodoulou, Christos, Razis, Evangelia, Papaspirou, Irene, Gousia, Anna, Petraki, Kalliopi, Poulakaki, Fiorita, Papadopoulou, Kyriaki, Karavasilis, Vasilios, Pectasides, Dimitrios G., Fountzilas, George

Volltext

Evaluation of the prognostic significance of RACGAP1, Ki67, and TOP2A mRNA expression in high-risk early breast cancer von Pliarchopoulou, Kyriaki, Gogas, Helen, Papadimitriou, Christos A., Wirtz, Ralph M, Kouvatseas, George, Timotheadou, Eleni, Stavridi, Flora, Christodoulou, Christos, Koutras, Angelos, Pisanidis, Nikolaos, Pentheroudakis, George E., Bafaloukos, Dimitris, Samantas, Epaminontas, Kalogeras, Konstantine T., Dimopoulos, Meletios A., Pectasides, Dimitrios G., Fountzilas, George

Volltext

Evaluation of the prognostic/predictive role of tumor EGFR and KRAS mutations in Greek metastatic non-small cell lung cancer patients treated with first-line chemotherapy von Linardou, Helena, Kosmidis, Paris A., Kotoula, Vassiliki, Karavasilis, Vasilios, Eleftheraki, Anastasia G, Lazaridis, Georgios, Daskalaki, Emily, Lakis, Sotiris, Charalambous, Elpida, Samantas, Epaminontas, Pectasides, Dimitrios G., Bafaloukos, Dimitris, Fountzilas, George

Volltext

Combination Regimen with Carboplatin, Epirubicin and Etoposide in Metastatic Carcinomas of Unknown Primary Site: A Hellenic Co-Operative Oncology Group Phase II Study von Briasoulis, Evangelos, Tsavaris, Nicholas, Fountzilas, George, Athanasiadis, Athanasios, Kosmidis, Paris, Bafaloukos, Dimitris, Skarlos, Dimosthenis, Samantas, Epaminondas, Pavlidis, Nicholas

Volltext

Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer von RAZIS, Evangelia, DIMOPOULOS, Athanassios-Meletios, KOSMIDIS, Paris, FOUNTZILAS, George, BAFALOUKOS, Dimitris, PAPADIMITRIOU, Christos, KALOGERA-FOUNTZILA, Anna, KALOFONOS, Haralambos, BRIASSOULIS, Evangelos, SAMANTAS, Epaminontas, KERAMOPOULOS, Antonios, PAVLIDIS, Nicholas

Volltext

Dose-Dense Sequentials Chemotherapy with Epirubicin and Paclitaxel in Advanced Breast Cancer von Razis, Evangelia, Dimopoulos, Athanassios-Meletios, Bafaloukos, Dimitris, Papadimitriou, Christos, Kalogera-Fountzila, Anna, Kalofonos, Haralambos, Briassoulis, Evangelos, Samantas, Epaminontas, Keramopoulos, Antonios, Pavlidis, Nicholas, Kosmidis, Paris, Fountzilas, George

Volltext

Subcutaneous low doses of interleukin-2 and recombinant interferon alpha with carboplatin and vinblastine in patients with advanced melanoma von RAFALOUKOS, D, FOUNTZILAS, G, SKARLOS, D, PAVLIDIS, N, BAKOYIANNIS, C, KARVOUNIS, N, KOSMIDIS, P

Volltext

The prognostic significance of immune changes in patients with renal cell carcinoma treated with interferon alfa-2b von KOSMIDIS, P. A, BAXEVANIS, C. N, PAPAMICHAIL, M, TSAVARIS, N, PAPANASTASIOU, M, ANASTASOPOULOS, E, BACOYLANNIS, C, MYLONAKIS, N, KARVOUNIS, N, BAFALOUKOS, D, KARABELIS, A

Volltext